Santhera Pharmaceuticals Holding AG announces the promotion of Geert Jan van Daal, MD, PhD, to Chief Commercial Officer and of Marc Schrader to Chief Technology Officer . Both will join the.
Pratteln, Switzerland, December 7, 2023 – Santhera Pharmaceuticals (SIX: SANN) announces the promotion of Geert Jan van Daal, MD, PhD, to Chief Commercial Officer (CCO) and of Marc Schrader to Chief Technology Officer (CTO). Both will join the six-member Executive Committee effective January 1, 2024. “Santhera is transitioning to the commercial phase and will make AGAMREE® (vamorolone) available to patients in Europe starting in Germany in early 2024, subject to approval by the European Commissi
Santhera Pharmaceuticals Holding AG: Santhera Appoints Executive Committee Members as it Transitions into Commercial Stage finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Beam Suntory will establish its own route-to-market strategy in France with the launch of Beam Suntory France in January 2024: with a team across sales, marketing and corporate functions supporting the in-market commercial business.
Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.